Sign in

CIK 0001712762 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

bioAffinity Technologies, Inc.

Sign in to watch
Ticker
BIAF
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465211056
Phone
210-698-5334
Business address
3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
Former names
bioAffinity Technologies, Inc.

Securities

  • BIAF Common Stock Nasdaq
  • BIAFW Warrant Nasdaq
  1. 8-K Event Results of operations
  2. 4 Grant or award Secretary, EVP, Gen. Counsel acquired 6,688 shares (grant or award)
  3. 4 Grant or award President, CEO acquired 23,885 shares (grant or award)
  4. 4 Grant or award Chief Operating Officer acquired 16,720 shares (grant or award)
  5. 4 Grant or award Chief Sci. & Med. Officer, EVP acquired 31,847 shares (grant or award)
  6. 4 Grant or award Executive Chairman acquired 11,943 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 31,847 shares (grant or award)
  8. 8-K Event Executive or director change
  9. 4 Grant or award Executive Chairman acquired 24,535 shares (grant or award)
  10. 4 Grant or award Director acquired 24,535 shares (grant or award)
  11. 4 Grant or award Director acquired 24,535 shares (grant or award)
  12. 4 Grant or award President, CEO acquired 24,535 shares (grant or award)
  13. 4 Grant or award Director acquired 24,535 shares (grant or award)
  14. 4 Grant or award Director acquired 11,867 shares (grant or award)
  15. 4 Grant or award Director acquired 24,535 shares (grant or award)
  16. 4 Grant or award Director acquired 24,535 shares (grant or award)
  17. 4 Grant or award Director acquired 12,668 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Executive or director change · Regulation FD disclosure
  20. 8-K Event Regulation FD disclosure · Other events

Page 14 of 21 · 401 filings